Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Tumoral
100%
Syngeneic Mice
100%
Anti-tumor Immune
100%
T-lymphoblasts
100%
Tumor Regression
100%
Tumor Cell Lysate
100%
Immune System Stimulation
100%
PKHB1
100%
Cell Death
50%
L5178Y
50%
Tumor
37%
Tumor Cells
25%
Acute Lymphoblastic Leukemia
25%
Tumor Establishment
25%
Immune Tolerance
25%
Low Immunogenicity
25%
Cluster of Differentiation 47 (CD47)
25%
T-cell ALL
25%
T Cells
12%
Treatment Options
12%
Immunogenicity
12%
Potential Therapeutics
12%
Cytokine Production
12%
Induced Damage
12%
Therapeutic Tool
12%
Rechallenge
12%
Anti-tumor Response
12%
Antitumor Immune Response
12%
Overall Survival
12%
Dendritic Cell Maturation
12%
Lymphoblast
12%
Immunogenic Potential
12%
Damage-associated Molecular Patterns
12%
Murine Tumors
12%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
12%
Cell Treatment
12%
Production Cell
12%
Prophylactic Vaccination
12%
Pediatric Cancer
12%
Hematological Cancer
12%
Agonist Peptide
12%
Immunogenic Cell Death
12%
Calreticulin Exposure
12%
Leukemia Relapse
12%
TSP-1
12%
Immunology and Microbiology
Tumor Cell
100%
Cell Death
100%
Cell Lysate
100%
Syngenic
100%
T Lymphoblast
100%
Immune System
100%
T Cell
80%
Immunogenicity
60%
Immunotherapy
40%
Immune Tolerance
40%
CD47
40%
Cell Maturation
20%
Immune Response
20%
Cell Line
20%
Agonist
20%
Cytokine Production
20%
Dendritic Cell
20%
Murine
20%
Overall Survival
20%
Lymphoblast Cell Line
20%
Thrombospondin 1
20%
Calreticulin
20%
Peptides
20%